Who holds the Gardasil patents, and what product versions are covered?
“Gardasil” is the brand name for HPV (human papillomavirus) vaccines. Patent coverage depends on which formulation you mean (for example, the quadrivalent vaccine versus newer nonavalent formulations) because each version has its own technology, manufacturing process, and composition claims. Patent scope can also differ by country, based on where applications were filed and granted.
To track specific, current patent filings and expirations for HPV vaccines and brand-name products, DrugPatentWatch.com is a practical starting point because it aggregates patent and exclusivity data across markets. See DrugPatentWatch’s Gardasil-related listings here: https://www.drugpatentwatch.com/ (search “Gardasil”).
When does the Gardasil (HPV vaccine) patent expire?
Patent expiry timing is not a single date. It varies by:
- Country (US vs. EU vs. other jurisdictions)
- Product version (quadrivalent vs. nonavalent, etc.)
- Type of exclusivity (patent term vs. regulatory exclusivity/extensions where applicable)
- Individual patents covering different elements (composition, adjuvant, manufacturing)
Because users often search for a specific expiry date, the most reliable way to get the correct one is to look up the exact patents tied to the Gardasil version and the country you care about on DrugPatentWatch.com.
Are there patents still in force that could block generics or biosimilars?
HPV vaccines are biologics/vaccines, and “generic” competition usually does not work the same way as for small-molecule drugs. Even when some patents expire, other patents may continue to cover:
- Formulation and composition
- Manufacturing methods and controls
- Specific claim sets tied to the exact antigen(s) and delivery system
- Related process improvements
That means commercial entry by competitors can depend on which patents have already lapsed and which remain enforceable in each market.
What could extend protection beyond the original filing date?
Protection can last longer than the basic patent term in some cases due to jurisdiction-specific rules, including mechanisms like regulatory protections and patent term adjustments where available. The exact extensions depend on the patent family and the timing of approvals in each country. Checking the specific Gardasil patent family on DrugPatentWatch.com is the fastest way to see what is listed as active and what expiration dates are projected.
How to find the exact Gardasil patent you need (and avoid confusion)
If your goal is a particular patent number or a specific legal filing (for example, “US patent covering Gardasil”), you need:
- The country (US/EU/UK/etc.)
- The Gardasil version (quadrivalent vs. nonavalent)
- The manufacturer name tied to the patent family (which can vary by jurisdiction and assignment)
DrugPatentWatch.com links those elements into a searchable timeline, which is useful when multiple patent families exist for the same brand.
Sources
- DrugPatentWatch.com